Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C Genotype 4-Reference-Cited by-同舟云学术

Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C Genotype 4

Author:

Abdel Ghaffar Tawhida Y.¹²,El Naghi Suzan¹³,Abdel Gawad Manal⁴,Helmy Sarah¹,Abdel Ghaffar Aisha⁵,Yousef Medhat⁶,Moafy Mohamad²

Affiliation:

1. Yassin Abdel Ghaffar Charity Center for Liver Disease and Research; Cairo Egypt

2. Department of Pediatrics; Ain Shams University; Cairo Egypt

3. Department of Pediatrics; National Hepatology & Tropical Medicine Research Institute; Cairo Egypt

4. Department of Pediatrics; Alexandria University; Alexandria Egypt

5. Department of Clinical Pathology; Ain Shams University; Cairo Egypt

6. Fibrosence Medical Center; Cairo Egypt

Funder

The Egyptian Cure Bank NGO

the Society of Friends of Liver Patients in the Arab World

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

Reference53 articles.

5. World Health Organization Global hepatitis report

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Hepatitis C;The Lancet;2023-09